GPR101

G protein-coupled receptor 101, the group of G protein-coupled receptors, Class A orphans

Basic information

Region (hg38): X:137023929-137033995

Links

ENSG00000165370NCBI:83550OMIM:300393HGNC:14963Uniprot:Q96P66AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pituitary adenoma, growth hormone-secreting, 2 (Strong), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Pituitary adenoma, growth hormone secreting, 2XLEndocrineSurveillance and/or awareness of cancer risk may allow early diagnosis of pituitary tumors (as well as related manifestations, such as hypertension, hypogonadism, diabetes mellitus, and osteoporosis), which could potentially be beneficial to allow early medical (eg, with somatostatin analogs, growth hormone receptor antagonists, dopamine agonists) or surgical treatment; Surveillance post-treatment may also be beneficial to detect recurrence/new adenomasEndocrine25470569; 25806920
The condition can involve microduplications including the gene

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GPR101 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR101 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
10
clinvar
3
clinvar
13
missense
22
clinvar
3
clinvar
6
clinvar
31
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 22 13 9

Variants in GPR101

This is a list of pathogenic ClinVar variants found in the GPR101 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-137030150-A-G Likely benign (Jun 06, 2018)722009
X-137030169-G-A Benign (Dec 02, 2022)751974
X-137030182-A-G not specified Uncertain significance (Sep 27, 2021)2252347
X-137030346-G-A Likely benign (Jul 01, 2022)2661525
X-137030363-T-C Uncertain significance (Oct 22, 2023)2902898
X-137030381-G-A GPR101-related disorder Benign (Jan 16, 2024)1590841
X-137030382-T-C Likely benign (Jan 24, 2018)727372
X-137030420-C-A Uncertain significance (Dec 06, 2023)2879531
X-137030450-C-T Benign (Jun 27, 2023)714970
X-137030515-G-C not specified Uncertain significance (Dec 12, 2023)3101361
X-137030519-T-G Uncertain significance (-)92023
X-137030533-C-T not specified Uncertain significance (Dec 22, 2023)3101360
X-137030534-G-A not specified Uncertain significance (Mar 02, 2023)2467997
X-137030539-C-G Uncertain significance (Dec 01, 2023)2699970
X-137030548-A-G Benign (Jan 31, 2024)1563029
X-137030572-T-A not specified Uncertain significance (Jan 22, 2024)2976970
X-137030573-C-T not specified Conflicting classifications of pathogenicity (Jun 30, 2023)2193756
X-137030574-G-A Likely benign (Oct 13, 2022)2096919
X-137030577-G-T Pituitary adenoma, growth hormone-secreting, 2 Pathogenic (Mar 26, 2015)192259
X-137030712-C-A not specified Uncertain significance (Jun 07, 2023)2513316
X-137030748-G-T Uncertain significance (Nov 02, 2022)2811610
X-137030751-C-G Pituitary adenoma, growth hormone-secreting, 2 • GPR101-related disorder Conflicting classifications of pathogenicity (Dec 22, 2023)167871
X-137030751-C-T Benign/Likely benign (Jan 13, 2024)445921
X-137030760-C-G not specified Uncertain significance (Jan 31, 2024)3101366
X-137030783-C-T GPR101-related disorder • not specified Conflicting classifications of pathogenicity (Nov 10, 2023)737459

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GPR101protein_codingprotein_codingENST00000298110 11527
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7040.29300000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6351812070.8760.00001543372
Missense in Polyphen6374.9630.840411261
Synonymous0.9857586.70.8650.000006801001
Loss of Function2.3518.300.1205.65e-7148

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Orphan receptor.;
Disease
DISEASE: Pituitary adenoma 2, growth hormone-secreting (PITA2) [MIM:300943]: A form of pituitary adenoma, a neoplasm of the pituitary gland and one of the most common neuroendocrine tumors. Pituitary adenomas are clinically classified as functional and non-functional tumors, and manifest with a variety of features, including local invasion of surrounding structures and excessive hormone secretion. Functional pituitary adenomas are further classified by the type of hormone they secrete. PITA2 is a growth hormone-secreting benign neoplasm, also known as somatotropinoma. It clinically results in acromegaly, a condition characterized by coarse facial features, protruding jaw, and enlarged extremities. Excessive production of growth hormone in children or adolescents before the closure of epiphyses causes gigantism, a condition characterized by abnormally tall stature. {ECO:0000269|PubMed:25470569}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0993

Intolerance Scores

loftool
0.117
rvis_EVS
0.66
rvis_percentile_EVS
84.55

Haploinsufficiency Scores

pHI
0.274
hipred
N
hipred_score
0.373
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.207

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gpr101
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Gene ontology

Biological process
adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-activating adrenergic receptor signaling pathway
Cellular component
integral component of plasma membrane;receptor complex
Molecular function
adrenergic receptor activity